Aug 1, 1995

Inhibition of bacterial growth in vitro by human ejaculate seminal plasma fraction 1 and its possible practical use in male infertility phenomenon

Journal of Assisted Reproduction and Genetics
Z H MarcusR Ginsberg

Abstract

The in vitro bacteriostatic effect on bacteria by a fraction of human ejaculate (HuSePl-Fr1) was studied. As bacterial indicators, Pseudomonas aeruginosa (Pa), total coliforms (Tc), fecal coliforms (Fc), Escherichia coli (Ec), and Staphylococcus aureus (Sa) were used. These bacterial strains are known as agents that cause urinary and sexually transmitted infections (STI). Preliminary results suggest that HuSePl-Fr1 has a significant in vitro bacteriostatic effect on Pa and Sa at 42 degrees C. In addition, Pa was inhibited at 37 degrees C after 48 hr incubation. The remaining bacterial indicators were not affected. The results indicate a possible protective role of HuSePl-Fr1 in treatment of infertile men due to genital infections.

  • References11
  • Citations1

Citations

Mentioned in this Paper

Pseudomonas Infections
Alkalescens-Dispar Group
Culture Media, Conditioned
Escherichia Coli Infections
Staphylococcal Infections
Reproductive Tract Infection
Pseudomonas aeruginosa
Seminal Plasma
Subfertility, Male
Staphylococcus aureus

About this Paper

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.